Douglass Winthrop Advisors LLC reduced its holdings in shares of Aetna Inc (NYSE:AET) by 15.5% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 3,000 shares of the company’s stock after selling 550 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Aetna were worth $609,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Kaizen Advisory LLC lifted its position in shares of Aetna by 143.9% during the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock worth $141,000 after buying an additional 452 shares during the last quarter. CSat Investment Advisory L.P. bought a new stake in shares of Aetna during the 2nd quarter worth $162,000. Sun Life Financial INC lifted its position in shares of Aetna by 252.0% during the 2nd quarter. Sun Life Financial INC now owns 887 shares of the company’s stock worth $163,000 after buying an additional 635 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its position in shares of Aetna by 3,076.7% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 953 shares of the company’s stock worth $175,000 after buying an additional 923 shares during the last quarter. Finally, HighPoint Advisor Group LLC bought a new stake in shares of Aetna during the 2nd quarter worth $208,000. Institutional investors and hedge funds own 83.49% of the company’s stock.
AET has been the subject of several recent analyst reports. Cantor Fitzgerald downgraded Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 price objective for the company. in a research report on Wednesday, August 22nd. Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a research report on Monday, August 6th. Finally, ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Eight analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Aetna presently has an average rating of “Hold” and an average price target of $203.77.
Shares of AET stock opened at $201.01 on Friday. The stock has a market capitalization of $66.41 billion, a PE ratio of 20.39, a P/E/G ratio of 1.74 and a beta of 0.69. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.44. Aetna Inc has a 1-year low of $149.69 and a 1-year high of $206.66.
Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.04 by $0.39. The company had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. Aetna had a return on equity of 20.66% and a net margin of 5.77%. The business’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.42 earnings per share. As a group, research analysts predict that Aetna Inc will post 11.31 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be paid a $0.50 dividend. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 0.99%. Aetna’s payout ratio is 20.28%.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Story: How analysts view the yield curve
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.